RELLY MER SEGOVIA: Open Payments
NPI 1780303248 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 30 payments from 7 companies in 2025. Trend: 2023 $693 · 2024 $1,069 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $225 |
| Madrigal Pharmaceuticals | 3 | $188 |
| Ardelyx, Inc. | 8 | $164 |
| Phathom Pharmaceuticals, Inc. | 3 | $85 |
| PFIZER INC. | 2 | $49 |
| Janssen Biotech, Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: REZDIFFRA, IBSRELA, LINZESS, VOQUEZNA, XELJANZ, CREON, MAVYRET, TREMFYA.
Industry payments across CA — which companies pay providers there.
